A team of researchers from New Jersey Institute of Technology (NJIT) and Children’s Hospital of Philadelphia (CHOP) have developed an algorithm through machine learning that helps predict sites of DNA methylation – a process that can change the activity of DNA without changing its overall structure – and could identify disease-causing mechanisms that would otherwise be missed by conventional screening methods. To read the full story.
Recent Posts
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
- Join NJACTS on 4/29 for a Multilingual Research Methods Workshop – Register by 4/22!
- NJIT’s Center for Translational Research Quickens Technology’s Pace to Market.
- Join Us for Clinical Trials Day on May 20th!
Categories
- Community (2,475)
- Covid (999)
- CTO Events (6)
- News (3,139)
- Pilots (21)